Methicillin-resistant S. aureus (MRSA) has emerged as an almost ubiquitous pathogen in both the community and hospital settings. The predominant clone responsible for community-associated MRSA ...

Methicillin-resistant Staphylococcus aureus (MRSA) is well known as one of the most frequent etiological agents of healthcare-associated infections. The epidemiology of MRSA is evolving with ...

Understanding MRSA's resistance: A novel cell division pathway sheds light on how this dangerous pathogen evades antibiotics, advancing our fight against superbugs. Antibiotics' contributions to ...

Staphylococcus aureus strains resistant to the antibiotic methicillin (MRSA for short) are particularly feared in hospitals. According to a study published at the beginning of November, there were ...

“TAXIS’ approach enables the use of reduced antibiotic doses without compromising pathogen kill rates and ... TAXIS’ lead asset is TXA709, an oral anti-MRSA (methicillin-resistant S.

If no action is taken to counter this threat more people will die of infectious diseases than of heart disease or cancer. We have discovered small-molecule antivirulence agents against MRSA and other ...

The microbe poses a significant threat to public health, made worse by the spread of methicillin-resistant Staphylococcus aureus bacteria (MRSA ... "It is a pathogen in dire need of control ...

“Drug-resistant pathogens, like MRSA, pose significant challenges for patients in hospitals and other healthcare facilities with a high mortality rate and huge cost burden. Zevtera will enable ...